Avalo Therapeutics (AVTX) Current Taxes (2017 - 2019)

Avalo Therapeutics has reported Current Taxes for 3 years, with the latest figure at $551671.0 in Q4 2019.

• For the quarter ending Q4 2019, Current Taxes fell 72.85% year-over-year to $551671.0; the trailing twelve-month figure through Dec 2019 stood at $551671.0 (down 72.85% YoY), and the FY2019 full-year result was $551671.0, down 72.85% from the prior year.
• Current Taxes for Q4 2019 stood at $551671.0, down from $1.0 million in the prior quarter.
• The five-year high for Current Taxes was $3.2 million in Q3 2017, with the low at $551671.0 in Q4 2019.
• Historically, Current Taxes has averaged $1.9 million across 3 years, with a median of $2.1 million in 2018.
• Annual changes were most pronounced in 2018 — Current Taxes retreated 10.04% — and 2019, when it sank 72.85%.
• Avalo Therapeutics' Current Taxes stood at $2.3 million in 2017, then dropped by 10.04% to $2.0 million in 2018, then slumped by 72.85% to $551671.0 in 2019.
• The last three Current Taxes figures came in at $551671.0 (Q4 2019), $1.0 million (Q3 2019), and $1.4 million (Q2 2019), per Business Quant data.